» Articles » PMID: 28440731

Pulmonary Venous Remodeling in COPD-pulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension

Overview
Journal Pulm Circ
Publisher Wiley
Specialty Pulmonary Medicine
Date 2017 Apr 26
PMID 28440731
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary vascular arterial remodeling is an integral and well-understood component of pulmonary hypertension (PH). In contrast, morphological alterations of pulmonary veins in PH are scarcely described. Explanted lungs (n = 101) from transplant recipients with advanced chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary arterial hypertension (IPAH) were analyzed for venous vascular involvement according to a pre-specified, semi-quantitative grading scheme, which categorizes the intensity of venous remodeling in three groups of incremental severity: venous hypertensive (VH) grade 0 = characterized by an absence of venous vascular remodeling; VH grade 1 = defined by a dominance of either arterialization or intimal fibrosis; and VH grade 2 = a substantial composite of arterialization and intimal fibrosis. Patients were grouped according to clinical and hemodynamic characteristics in three groups: COPD non-PH, COPD-PH, and IPAH, respectively. Histological specimens were examined by a cardiovascular pathologist blinded to clinical and hemodynamic data. Pathological alterations of pulmonary veins were present in all hemodynamic groups, with the following incidences of VH grade 0/1/2: 34/66/0% in COPD non-PH; 19/71/10% in COPD-PH; and 11/61/28% in IPAH. In COPD, explorative correlation analysis of venous remodeling suggested a modest positive correlation with systolic and mean pulmonary artery pressure ( P = 0.032, respectively) and an inverse modest correlation with diffusion capacity for carbon monoxide ( P = 0.027). In addition, venous remodeling correlated positively with the degree of arterial remodeling ( P = 0.014). In COPD-PH and IPAH, advanced forms of pulmonary venous remodeling are present, emphasizing that the disease is not exclusively restricted to arterial lesions. In addition, venous remodeling may be related to the hemodynamic severity, but more rigorous analysis is required to clearly define potential relationships.

Citing Articles

Higher small pulmonary artery and vein volume on computed tomography is associated with mortality in current and former smokers.

Kwee A, Andrinopoulou E, van der Veer T, Gallardo-Estrella L, Charbonnier J, Humphries S EBioMedicine. 2024; 108:105366.

PMID: 39353280 PMC: 11464249. DOI: 10.1016/j.ebiom.2024.105366.


Expiratory Venous Volume and Arterial Tortuosity are Associated with Disease Severity and Mortality Risk in Patients with COPD: Results from COSYCONET.

Stoleriu M, Pienn M, Joerres R, Alter P, Fero T, Urschler M Int J Chron Obstruct Pulmon Dis. 2024; 19:1515-1529.

PMID: 38974817 PMC: 11227296. DOI: 10.2147/COPD.S458905.


Pulmonary hypertension across the spectrum of left heart and lung disease.

Borlaug B, Larive B, Frantz R, Hassoun P, Hemnes A, Horn E Eur J Heart Fail. 2024; 26(7):1642-1651.

PMID: 38837273 PMC: 11269034. DOI: 10.1002/ejhf.3302.


Quantitative Assessment Characteristics of Small Pulmonary Vessel Remodelling in Populations at High Risk for COPD and Smokers Using Low-Dose CT.

Pu Y, Zhou X, Zhang D, Guan Y, Xia Y, Liu S Int J Chron Obstruct Pulmon Dis. 2024; 19:51-62.

PMID: 38205400 PMC: 10778209. DOI: 10.2147/COPD.S436242.


Platelet-derived growth factor-BB induces pulmonary venous smooth muscle cells proliferation by upregulating calcium sensing receptor under hypoxic conditions.

Liu R, Xu J, Jiang Y, Hong W, Li S, Fu Z Cytotechnology. 2021; 73(2):189-201.

PMID: 33927476 PMC: 8035351. DOI: 10.1007/s10616-021-00456-5.


References
1.
Heath D, Edwards J . Histological changes in the lung in diseases associated with pulmonary venous hypertension. Br J Dis Chest. 1959; 53(1):8-18. DOI: 10.1016/s0007-0971(59)80105-4. View

2.
Mandel J, Mark E, Hales C . Pulmonary veno-occlusive disease. Am J Respir Crit Care Med. 2000; 162(5):1964-73. DOI: 10.1164/ajrccm.162.5.9912045. View

3.
Dorfmuller P, Gunther S, Ghigna M, de Montpreville V, Boulate D, Paul J . Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature. Eur Respir J. 2014; 44(5):1275-88. DOI: 10.1183/09031936.00169113. View

4.
Hurdman J, Condliffe R, Elliot C, Swift A, Rajaram S, Davies C . Pulmonary hypertension in COPD: results from the ASPIRE registry. Eur Respir J. 2012; 41(6):1292-301. DOI: 10.1183/09031936.00079512. View

5.
Ghigna M, Guignabert C, Montani D, Girerd B, Jais X, Savale L . BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension. Eur Respir J. 2016; 48(6):1668-1681. DOI: 10.1183/13993003.00464-2016. View